- Home
- MAPS vs IKT Comparison
MAPS vs IKT Comparison
Compare MAPS & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAPS
- IKT
- Stock Information
- Founded
- MAPS 2008
- IKT 2008
- Country
- MAPS United States
- IKT United States
- Employees
- MAPS N/A
- IKT N/A
- Industry
- MAPS Computer Software: Prepackaged Software
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- MAPS Technology
- IKT Health Care
- Exchange
- MAPS Nasdaq
- IKT Nasdaq
- Market Cap
- MAPS 134.9M
- IKT 159.2M
- IPO Year
- MAPS N/A
- IKT 2020
- Fundamental
- Price
- MAPS $1.29
- IKT $2.72
- Analyst Decision
- MAPS Strong Buy
- IKT Strong Buy
- Analyst Count
- MAPS 1
- IKT 2
- Target Price
- MAPS $2.61
- IKT $6.50
- AVG Volume (30 Days)
- MAPS 1.4M
- IKT 288.1K
- Earning Date
- MAPS 11-12-2024
- IKT 11-14-2024
- Dividend Yield
- MAPS N/A
- IKT N/A
- EPS Growth
- MAPS N/A
- IKT N/A
- EPS
- MAPS N/A
- IKT N/A
- Revenue
- MAPS $183,311,000.00
- IKT $1.00
- Revenue This Year
- MAPS N/A
- IKT N/A
- Revenue Next Year
- MAPS $7.86
- IKT N/A
- P/E Ratio
- MAPS N/A
- IKT N/A
- Revenue Growth
- MAPS N/A
- IKT N/A
- 52 Week Low
- MAPS $0.70
- IKT $1.12
- 52 Week High
- MAPS $1.65
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- MAPS 45.35
- IKT 41.71
- Support Level
- MAPS $1.26
- IKT $2.55
- Resistance Level
- MAPS $1.52
- IKT $2.90
- Average True Range (ATR)
- MAPS 0.10
- IKT 0.29
- MACD
- MAPS -0.03
- IKT -0.08
- Stochastic Oscillator
- MAPS 9.37
- IKT 18.09
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.